Bayer's Mammography Screening Injection Approved by FDA
23 Junio 2023 - 1:36PM
Noticias Dow Jones
By Sabela Ojea
Bayer said Friday the Food and Drug Administration has approved
its Ultravist injection to visualize breast lesions as an adjunct
to mammographies or ultrasounds.
The pharmaceutical company said Ultravist-300 and -370 gives
physicians a new imaging option beyond conventional
mammographies.
"The new FDA-approved indication aligns with the recent
increased focus on supplemental imaging needs for women at a higher
risk for breast cancer," Bayer said.
Ultravist is an injection for intravenous and intra-arterial
use.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 23, 2023 14:21 ET (18:21 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Bayer Aktiengesellschaft (PK) (OTCMarkets): 0 recent articles
Más de Bayer Aktiengesellschaft (PK) Artículos de Noticias